Notificação de entrada na fase nacional - PCT
#1.3
06/30/2026
RPI 2895
Application data
Number
112025018353Type
Filing
Publication
PCT
EP2024055281 Examination has not been requested yet. Without that request by 02/28/2027, the application is definitively abandoned (art. 33 of the Brazilian IP Act).
Deadline to request examination:02/28/2027(187 days left)
Latest action published by the INPI: 06/30/2026. We update with every new RPI gazette, published weekly.
Applicants
SANOFI
FR
Inventors
A. B. (pessoa física)
FR
A. L. (pessoa física)
FR
J. S. (pessoa física)
FR
M. C. (pessoa física)
FR
R. M. (pessoa física)
US
IPC Classification
Priority claims
EP
23305267.9 · 03/01/2023
Abstract
USO DE IMUNOCONJUGADOS DE ANTI-CEACAM5 PARA TRATAR CÂNCERES NEUROENDÓCRINOS QUE EXPRESSAM CEACAM5. A presente invenção refere-se a métodos para tratar cânceres neuroendócrinos usando imunoconjugados compreendendo um anticorpo que se liga especificamente a hCEACAM5, em particular a hCEACAM5.
Publications in the Brazilian Industrial Property Gazette (RPI).
#1.3
06/30/2026
RPI 2895
#1.1
09/09/2025
RPI 2853
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.